AmplatzerTM Duct Occluder
ABBOTT MEDICAL · Decision date May 28, 2026
What did the FDA decide?
FDA records P020024/S073 as a supplement to PMA P020024, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated May 28, 2026.
FDA approval order statement
adding an alternate polyethylene terephthalate (PET) yarn supplier
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- May 28, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P020024/S073
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- MAE
- Decision code
- OK30
- Decision date
- May 28, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: OCCLUDER, PATENT DUCTUS, ARTERIOSUS.
- Applicant
- Abbott Medical
- Product code
- MAE
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P020024/S071 · Related supplement
Amplatzer Duct Occluder; Amplatzer Duct Occluder II; Amplatzer Piccolo Occluder
P020024/S072 · Related supplement
Amplatzer Piccolo Occluder
P020024/S073 received
Application receipt date recorded by FDA.
P020024/S073 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P020024. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P020024
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Oct 23, 2025 | FDA | |
Amplatzer Piccolo OccluderP020024/S072 | ABBOTT MEDICAL | PMA supplement | Feb 12, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 177 County Rd. B E., St. Paul, MN, 55117
Sources and methodology
- Original FDA record: P020024/S073
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
